A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Clinical trial NCT06641466 · RECRUITING
Trial details
- NCT number
- NCT06641466
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-11
- Primary completion
- 2026-11-29
- Enrollment
- 723
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.